The Board of Senzime has decided that the half-year financial report is postponed to August 31, 2016.
The previously announced date of the half-year financial report, August 22, is postponed to August 31, 2016. For further information, please contact: Lena Söderström, CEO of Senzime ABTel: +46 708-16 39 12, email: lena.soderstrom@senzime.com TO THE EDITORSAbout Senzime Senzime develops unique patient-oriented monitoring systems that make it possible to assess patients' biochemical and physiological processes before, during and after surgery. The portfolio of technologies includes bedside systems that enable automated and continuous monitoring of life-critical substances such